Back to calendar
Ultragenyx Pharmaceutical Inc. (RARE) Earnings
RARE reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-1.22
Actual EPS: $-1.84
EPS surprise: -23.67%
Company overview
Market Cap$3.3B
PriceUSD 33.82
EPS (TTM)-6.11
52-week high39.89
52-week low18.29
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees1,371